| P50 | author | Turhan Canli | Q60945401 |
| | David A Bennett | Q66739430 |
| | Dirk Moser | Q98665024 |
| P2093 | author name string | Lei Yu | |
| | Emily I Chen | |
| | Antonius Koller | |
| | Magdalena Jurkiewicz | |
| P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
| | The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam | Q24561949 |
| | A gene atlas of the mouse and human protein-encoding transcriptomes | Q24568043 |
| | Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A) | Q24655420 |
| | PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 |
| | An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database | Q27861106 |
| | Large-scale analysis of the yeast proteome by multidimensional protein identification technology | Q28131778 |
| | Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search | Q28211385 |
| | An automated multidimensional protein identification technology for shotgun proteomics | Q28214478 |
| | Regulation of mRNA translation and stability by microRNAs | Q29547304 |
| | Primer3--new capabilities and interfaces | Q29614816 |
| | Analysis of quantitative proteomic data generated via multidimensional protein identification technology | Q30695922 |
| | Systematic analysis of bicistronic reporter assay data | Q30841533 |
| | Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). | Q33226693 |
| | SV2 regulates neurotransmitter release via multiple mechanisms | Q34304904 |
| | Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS | Q34506200 |
| | Genetically Epilepsy-Prone Rats Display Anxiety-Like Behaviors and Neuropsychiatric Comorbidities of Epilepsy. | Q55613757 |
| | DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies | Q56992616 |
| | A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research | Q58798030 |
| | A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy | Q64056463 |
| | Religious Orders Study and Rush Memory and Aging Project | Q88978899 |
| | Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways | Q89243403 |
| | Increased Expression of miR-155p5 in Amygdala of Children With Autism Spectrum Disorder | Q90012328 |
| | Genetic stratification of depression by neuroticism: revisiting a diagnostic tradition | Q90431881 |
| | Genetic architecture of subcortical brain structures in 38,851 individuals | Q90860115 |
| | Neurite-Enriched MicroRNA-218 Stimulates Translation of the GluA2 Subunit and Increases Excitatory Synaptic Strength | Q91172990 |
| | Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans | Q92267334 |
| | MicroRNAs expressed in depression and their associated pathways: A systematic review and a bioinformatics analysis | Q92272539 |
| | Levetiracetam for managing neurologic and psychiatric disorders | Q34957747 |
| | Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapy | Q35539645 |
| | Overview and findings from the rush Memory and Aging Project | Q36226167 |
| | Potential of levetiracetam in mood disorders: a preliminary review | Q36670842 |
| | Levetiracetam as adjunctive therapy for refractory anxiety disorders. | Q36904815 |
| | Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex | Q37120426 |
| | A brief review on the mechanisms of miRNA regulation | Q37319155 |
| | MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship | Q37992965 |
| | Context-specific microRNA function in developmental complexity. | Q38077761 |
| | Determining the role of microRNAs in psychiatric disorders | Q38384194 |
| | A comprehensive regional analysis of genome-wide expression profiles for major depressive disorder | Q38434101 |
| | MicroRNA-182 regulates amygdala-dependent memory formation | Q38455718 |
| | Comparisons of mass spectrometry compatible surfactants for global analysis of the mammalian brain proteome | Q38512252 |
| | Amygdalar expression of the microRNA miR-101a and its target Ezh2 contribute to rodent anxiety-like behaviour | Q38726228 |
| | Heritability of personality: A meta-analysis of behavior genetic studies. | Q39008740 |
| | Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. | Q39753490 |
| | Enhancements and modifications of primer design program Primer3. | Q40230955 |
| | MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c | Q41084643 |
| | Differential expression of synaptic vesicle protein 2 (SV2) isoforms. | Q41443403 |
| | An Extended Twin-Pedigree Study of Neuroticism in the Netherlands Twin Register | Q42697625 |
| | Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance | Q42775825 |
| | Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial | Q43024206 |
| | Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy | Q43836888 |
| | Effect of levetiracetam on depression and anxiety in adult epileptic patients | Q44677494 |
| | Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism | Q44904590 |
| | A population-based twin study of the relationship between neuroticism and internalizing disorders | Q44919398 |
| | The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample | Q44924966 |
| | Differential stress induced c-Fos expression and identification of region-specific miRNA-mRNA networks in the dorsal raphe and amygdala of high-responder/low-responder rats | Q45047454 |
| | Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice | Q46223198 |
| | Positive and negative psychotropic effects of levetiracetam | Q46516531 |
| | Levetiracetam in social phobia: a placebo controlled pilot study | Q46705996 |
| | The impact of levetiracetam on challenging behavior | Q46940911 |
| | Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism. | Q47562858 |
| | Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response | Q47566414 |
| | Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 |
| | miR-135a Regulates Synaptic Transmission and Anxiety-Like Behavior in Amygdala. | Q48166883 |
| | Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study | Q48398251 |
| | Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding | Q48886998 |
| | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. | Q50015658 |
| | Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. | Q50786678 |
| | Netherlands twin family study of anxious depression (NETSAD). | Q51064548 |
| | Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. | Q51906679 |
| | Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. | Q51910603 |
| | Levetiracetam for treatment-refractory posttraumatic stress disorder. | Q51919873 |
| P433 | issue | 1 | |
| P921 | main subject | genome-wide association study | Q1098876 |
| P304 | page(s) | 297 | |
| P577 | publication date | 2020-08-24 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218 | |
| P478 | volume | 10 | |